Medical News Summary: Drug company obtains orphan status for its new cancer drug
About: Drug company obtains orphan status for its new cancer drug
Date: 27 January 2005
Source: Forbes
Medical News Summary (summary of medical news story as reported by Forbes): Sonus Pharmaceuticals Inc. has had its cancer drug, Tocosol Paclitaxel, approved as an orphan drug for the treatment of non-superficial urothelial cancer such as bladder cancer. The company is also aiming to have the drug approved for treatment of breast, ovarian and lung cancer. Current trials involve bladder cancer.
URL: http://www.forbes.com/smallbusiness/feeds/ap/2005/01/27/ap1787099.html
Related Disease Topics: Cancer, Urothelial cancer, Bladder cancer, Ovarian cancer, Lung cancer, Breast cancer
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Medication
- Research
- medication and cancer
- Medication and urothelial cancer
- medication and bladder cancer
- medication and ovarian cancer
- medication and lung cancer
- medication and breast cancer
- research and cancer
- Research and urothelial cancer
- research and bladder cancer
- research and ovarian cancer
- research and lung cancer
- research and breast cancer
Medical Tools & Articles:
Next articles:
Medical Articles: